Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Halobetasol Propionate Spray in Atopic Dermatitis
NCT03245385Phase 2Terminated
- Sponsor
- Sun Pharma
- Start
- Jul 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Halobetasol propionate 0.05% lotion in atopic dermatitis (AD), sponsored by Sun Pharma. Primary endpoint: Investigator Global Assessment at 14 days. Started Jul 2017; status: terminated.
02
Drugs
Halobetasol propionate 0.05% lotion
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03245385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03245385.